WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical company, today announced positive data from the STARLYNG-1 (LYN-005-C-301) study, comparing the ...
BOTHELL, Wash., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of ...
Novo Nordisk is preparing a new Phase 3 trial that compares two injection versions of its experimental obesity drug CagriSema against placebo in adults with excess body weight. Officially titled “A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results